Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Heterozygote of TAP1 Codon637 decreases susceptibility to HPV infection but increases susceptibility to esophageal cancer among the Kazakh populations.

Zou N, Yang L, Chen L, Li T, Jin T, Peng H, Zhang S, Wang D, Li R, Liu C, Jiang J, Wang L, Liang W, Hu J, Li S, Wu C, Cui X, Chen Y, Li F.

J Exp Clin Cancer Res. 2015 Jul 25;34:70. doi: 10.1186/s13046-015-0185-y.

2.

Molecular backgrounds of ERAP1 downregulation in cervical carcinoma.

Mehta AM, Osse M, Kolkman-Uljee S, Fleuren GJ, Jordanova ES.

Anal Cell Pathol (Amst). 2015;2015:367837. doi: 10.1155/2015/367837.

3.

Genetics and vaccines in the era of personalized medicine.

Castiblanco J, Anaya JM.

Curr Genomics. 2015 Feb;16(1):47-59. doi: 10.2174/1389202916666141223220551.

4.

Differences in genetic variation in antigen-processing machinery components and association with cervical carcinoma risk in two Indonesian populations.

Mehta AM, Spaans VM, Mahendra NB, Osse EM, Vet JN, Purwoto G, Surya IG, Cornian S, Peters AA, Fleuren GJ, Jordanova ES.

Immunogenetics. 2015 Jun;67(5-6):267-75. doi: 10.1007/s00251-015-0834-5.

5.

Association of TAP gene polymorphisms and risk of cervical intraepithelial neoplasia.

Natter C, Polterauer S, Rahhal-Schupp J, Cacsire Castillo-Tong D, Pils S, Speiser P, Zeillinger R, Heinze G, Grimm C.

Dis Markers. 2013;35(2):79-84. doi: 10.1155/2013/368732.

6.

HLA class I alleles are associated with peptide-binding repertoires of different size, affinity, and immunogenicity.

Paul S, Weiskopf D, Angelo MA, Sidney J, Peters B, Sette A.

J Immunol. 2013 Dec 15;191(12):5831-9. doi: 10.4049/jimmunol.1302101.

7.

How early studies on secreted and membrane protein quality control gave rise to the ER associated degradation (ERAD) pathway: the early history of ERAD.

Needham PG, Brodsky JL.

Biochim Biophys Acta. 2013 Nov;1833(11):2447-57. doi: 10.1016/j.bbamcr.2013.03.018. Review.

8.

Graphene oxide, but not fullerenes, targets immunoproteasomes and suppresses antigen presentation by dendritic cells.

Tkach AV, Yanamala N, Stanley S, Shurin MR, Shurin GV, Kisin ER, Murray AR, Pareso S, Khaliullin T, Kotchey GP, Castranova V, Mathur S, Fadeel B, Star A, Kagan VE, Shvedova AA.

Small. 2013 May 27;9(9-10):1686-90. doi: 10.1002/smll.201201546.

9.

Orf virus interferes with MHC class I surface expression by targeting vesicular transport and Golgi.

Rohde J, Emschermann F, Knittler MR, Rziha HJ.

BMC Vet Res. 2012 Jul 18;8:114. doi: 10.1186/1746-6148-8-114.

10.

Immunization route dictates cross-priming efficiency and impacts the optimal timing of adjuvant delivery.

Bouvier I, Jusforgues-Saklani H, Lim A, LemaƮtre F, Lemercier B, Auriau C, Nicola MA, Leroy S, Law HK, Bandeira A, Moon JJ, Bousso P, Albert ML.

Front Immunol. 2011 Dec 8;2:71. doi: 10.3389/fimmu.2011.00071.

11.

Interplay between carbohydrate and lipid in recognition of glycolipid antigens by natural killer T cells.

Pei B, Vela JL, Zajonc D, Kronenberg M.

Ann N Y Acad Sci. 2012 Apr;1253:68-79. doi: 10.1111/j.1749-6632.2011.06435.x. Review.

12.

The unfolded protein response (UPR)-activated transcription factor X-box-binding protein 1 (XBP1) induces microRNA-346 expression that targets the human antigen peptide transporter 1 (TAP1) mRNA and governs immune regulatory genes.

Bartoszewski R, Brewer JW, Rab A, Crossman DK, Bartoszewska S, Kapoor N, Fuller C, Collawn JF, Bebok Z.

J Biol Chem. 2011 Dec 2;286(48):41862-70. doi: 10.1074/jbc.M111.304956.

13.

A potential role for shed soluble major histocompatibility class I molecules as modulators of neurite outgrowth.

Washburn LR, Zekzer D, Eitan S, Lu Y, Dang H, Middleton B, Evans CJ, Tian J, Kaufman DL.

PLoS One. 2011 Mar 31;6(3):e18439. doi: 10.1371/journal.pone.0018439.

14.

Identification of key amino acid residues that determine the ability of high risk HPV16-E7 to dysregulate major histocompatibility complex class I expression.

Heller C, Weisser T, Mueller-Schickert A, Rufer E, Hoh A, Leonhardt RM, Knittler MR.

J Biol Chem. 2011 Apr 1;286(13):10983-97. doi: 10.1074/jbc.M110.199190.

15.

Transgenic mice with enhanced neuronal major histocompatibility complex class I expression recover locomotor function better after spinal cord injury.

Joseph MS, Bilousova T, Zdunowski S, Wu ZP, Middleton B, Boudzinskaia M, Wong B, Ali N, Zhong H, Yong J, Washburn L, Escande-Beillard N, Dang H, Edgerton VR, Tillakaratne NJ, Kaufman DL.

J Neurosci Res. 2011 Mar;89(3):365-72. doi: 10.1002/jnr.22557.

16.

IAP inhibitors enhance co-stimulation to promote tumor immunity.

Dougan M, Dougan S, Slisz J, Firestone B, Vanneman M, Draganov D, Goyal G, Li W, Neuberg D, Blumberg R, Hacohen N, Porter D, Zawel L, Dranoff G.

J Exp Med. 2010 Sep 27;207(10):2195-206. doi: 10.1084/jem.20101123.

17.

Engineering superior DNA vaccines: MHC class I single chain trimers bypass antigen processing and enhance the immune response to low affinity antigens.

Li L, Herndon JM, Truscott SM, Hansen TH, Fleming TP, Goedegebuure P, Gillanders WE.

Vaccine. 2010 Feb 23;28(8):1911-8. doi: 10.1016/j.vaccine.2009.10.096.

18.

The synthesis of truncated polypeptides for immune surveillance and viral evasion.

Cardinaud S, Starck SR, Chandra P, Shastri N.

PLoS One. 2010 Jan 21;5(1):e8692. doi: 10.1371/journal.pone.0008692.

19.

ER stress affects processing of MHC class I-associated peptides.

Granados DP, Tanguay PL, Hardy MP, Caron E, de Verteuil D, Meloche S, Perreault C.

BMC Immunol. 2009 Feb 16;10:10. doi: 10.1186/1471-2172-10-10.

20.

The MHC class I peptide repertoire is molded by the transcriptome.

Fortier MH, Caron E, Hardy MP, Voisin G, Lemieux S, Perreault C, Thibault P.

J Exp Med. 2008 Mar 17;205(3):595-610. doi: 10.1084/jem.20071985.

Items per page

Supplemental Content

Support Center